Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve we hereby wish to inform you ....
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shilpa Medicare Ltd has informed exchanges that its Board meeting is scheduled for 22 May 2026. The agenda includes consideration and approval of the Audited Standalone and Consolidated Financial Results for Q4 and the full year ended 31 March 2026, along with the statutory auditors' report. The Board will also consider recommending a dividend for FY 2025-26. The company has closed its insider trading window since 01 April 2026, which will remain shut until 48 hours after the results are declared.
This is a routine pre-result announcement. The 22 May meeting is in line with typical earnings announcement timelines. Investors should note that the trading window remains closed for insiders until after results, reducing the risk of information leakage.